ASIA-PACIFIC COUGH SYRUP MARKET 2023-2030

Lifesciences | Pharmaceuticals

ASIA-PACIFIC COUGH SYRUP MARKET 2023-2030

Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report suggests that the Asia-Pacific cough syrup market is assessed to witness robust growth with a CAGR of 4.01% over the forecasting years 2023-2030.


Report scope can be customized per your requirements - Request Free Sample Report 

The studied region includes the following countries:

•         China

•         Japan

•         South Korea

•         India

•         Australia & New Zealand

•         ASEAN Countries

•         Rest of Asia-Pacific

Healthcare product and pharmacy accessibility is on the rise across various Asia-Pacific nations. This increased accessibility has led to the easy availability of cough syrups for consumers. Furthermore, many countries are witnessing an increase in their aging populations, leading to vulnerability to respiratory ailments among the elderly, consequently driving up the demand for tailored cough syrups. However, the introduction of novel cough syrup medications can face obstacles due to stringent regulatory standards and approval processes.

China leads with the majority of the share in the given market. The nation’s prominent role as a major exporter of active pharmaceutical ingredients (API) has significantly impacted the domestic cough syrup market. Leveraging its robust pharmaceutical industry and API production capabilities, China provides essential components for cough syrup and other pharmaceutical products on a global scale. This fuels domestic cough syrup manufacturing and solidifies China’s reputation as a dependable global supplier, creating opportunities for the cough syrup market.

The Japanese government’s dedication to providing accessible and affordable healthcare significantly boosts the demand for cough syrups. The nation boasts a strong national healthcare policy, prioritizing the affordability and accessibility of healthcare products, including medications. This commitment is realized through active regulation of drug prices, promotion of generic medication usage, and negotiations with pharmaceutical firms to manage healthcare expenses. As a result, this strategy guarantees that cough syrups and other vital medications remain affordable for the elderly and the general public. Hence, these factors widen the overall scope of the cough syrup market.

Cough syrups are commonly utilized by adults experiencing weakened immune systems due to the natural aging process. This increased vulnerability to respiratory ailments, such as the common cold, flu, or bronchitis, makes adults more prone to these illnesses than children. Moreover, adults often encounter a greater array of environmental factors that can trigger respiratory irritation and coughing. This may result from exposure to various contaminants, allergens, and occupational hazards. These factors collectively contribute to the heightened susceptibility of adults to coughing-related issues. The market is broadly segmented into age group, distribution channel, and product type. The age group is further sectioned into adults, pediatric, and adolescents.

The renowned companies in the market include The Himalaya Wellness Company, Acella Pharmaceuticals LLC, Merck KGaA, Abbott Laboratories, Glenmark Pharmaceuticals Limited, and Dabur India Ltd.

Himalaya Wellness, a contemporary Ayurvedic enterprise, offers an extensive range of wellness merchandise harnessing the advantages of herbs. With a global presence spanning more than 100 nations, the company offers a comprehensive selection of scientifically-researched herbal concoctions, USDA-certified organic individual herbs, and personal care items. Its corporate headquarters is situated in Bangalore, Karnataka, India.

 

KEY DELIVERABLES OF THE REPORT:

·       Market CAGR during the forecasting years 2023-2030

·       Detailed data highlighting key insights, industry components, and market strategies

·       Comprehensive information and estimation of the cough syrup market revenue growth in the Asia-Pacific and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·       A wide-ranging study of factors that will challenge the APAC cough syrup market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE COUGH SYRUP MARKET

2.1.1. COVID-19 IMPACT

2.1.2. UKRAINE-RUSSIA WAR IMPACT

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTES

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. THREAT OF COMPETITIVE RIVALRY

2.3. INDUSTRY COMPONENTS

2.3.1. RAW MATERIALS

2.3.2. MANUFACTURERS

2.3.3. DISTRIBUTORS

2.3.4. RETAILERS

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. HIGH INCIDENCE OF RESPIRATORY AILMENTS

2.6.2. VULNERABILITY TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION

2.6.3. INNOVATIONS IN COUGH SYRUPS

2.7. MARKET CHALLENGES

2.7.1. OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUPS

2.7.2. STRICT REGULATORY REQUIREMENTS

2.7.3. INCREASING COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS

2.8. MARKET OPPORTUNITIES

2.8.1. SELF-MEDICATION TRENDS INCREASE DEMAND FOR OTC DRUGS

2.8.2. HERBAL COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE

2.8.3. EASE OF PURCHASE OFFERED BY E-COMMERCE CHANNELS

2.8.4. AVAILABILITY OF SUGAR-FREE COUGH SYRUPS

2.8.5. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9. ANALYST PERSPECTIVE

3. ASIA-PACIFIC COUGH SYRUP MARKET – BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS

3.2. COMBINATION MEDICINES

3.3. EXPECTORANTS

4. ASIA-PACIFIC COUGH SYRUP MARKET – BY AGE GROUP

4.1. ADULTS

4.2. ADOLESCENTS

4.3. PEDIATRIC

5. ASIA-PACIFIC COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACIES

5.2. HOSPITAL PHARMACIES

5.3. E-PHARMACIES

6. ASIA-PACIFIC COUGH SYRUP MARKET – BY COUNTRY OUTLOOK

6.1. CHINA

6.1.1. CHINA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2. JAPAN

6.2.1. JAPAN COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3. INDIA

6.3.1. INDIA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.4. SOUTH KOREA

6.4.1. SOUTH KOREA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5. ASEAN COUNTRIES

6.5.1. ASEAN COUNTRIES COUGH SYRUP MARKET FORECAST & PROSPECTS

6.6. AUSTRALIA & NEW ZEALAND

6.6.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET FORECAST & PROSPECTS

6.7. REST OF ASIA-PACIFIC

6.7.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE

7.1. GSK PLC

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY STRENGTHS

7.1.4. KEY CHALLENGES

7.2. PFIZER INC

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY STRENGTHS

7.2.4. KEY CHALLENGES

7.3. NOVARTIS AG

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY STRENGTHS

7.3.4. KEY CHALLENGES

7.4. RECKITT BENCKISER GROUP PLC

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY STRENGTHS

7.4.4. KEY CHALLENGES

7.5. THE PROCTER & GAMBLE COMPANY

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY STRENGTHS

7.5.4. KEY CHALLENGES

7.6. SANOFI SA

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY STRENGTHS

7.6.4. KEY CHALLENGES

7.7. CIPLA LIMITED

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY STRENGTHS

7.7.4. KEY CHALLENGES

7.8. KENVUE INC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY STRENGTHS

7.8.4. KEY CHALLENGES

7.9. ASTRAZENECA PLC

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY STRENGTHS

7.9.4. KEY CHALLENGES

7.10. ACELLA PHARMACEUTICALS LLC

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY STRENGTHS

7.10.4. KEY CHALLENGES

7.11. THE HIMALAYA WELLNESS COMPANY

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY STRENGTHS

7.11.4. KEY CHALLENGES

7.12. MERCK KGAA

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY STRENGTHS

7.12.4. KEY CHALLENGES

7.13. ABBOTT LABORATORIES

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY STRENGTHS

7.13.4. KEY CHALLENGES

7.14. GLENMARK PHARMACEUTICALS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY STRENGTHS

7.14.4. KEY CHALLENGES

7.15. DABUR INDIA LTD

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY STRENGTHS

7.15.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: INDUSTRY COMPONENTS

FIGURE 2: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 3: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 5: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)

FIGURE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)

FIGURE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: CHINA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: JAPAN COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: INDIA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 17: SOUTH KOREA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 18: ASEAN COUNTRIES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 19: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 20: REST OF ASIA-PACIFIC COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying